Our findings within SCA1 are likely not unique and open the possibility of such mechanistic complexity for other polyQ diseases and the broader class of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. This evidence concerns the gene ATXN1 and Parkinson disease.